A detailed history of Two Sigma Investments, LP transactions in Merus N.V. stock. As of the latest transaction made, Two Sigma Investments, LP holds 593,039 shares of MRUS stock, worth $24.8 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
593,039
Previous 633,227 6.35%
Holding current value
$24.8 Million
Previous $37.5 Million 20.92%
% of portfolio
0.07%
Previous 0.09%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$47.19 - $58.84 $1.9 Million - $2.36 Million
-40,188 Reduced 6.35%
593,039 $29.6 Million
Q2 2024

Aug 14, 2024

SELL
$39.81 - $60.2 $3.14 Million - $4.75 Million
-78,882 Reduced 11.08%
633,227 $37.5 Million
Q1 2024

May 15, 2024

BUY
$28.03 - $51.82 $11.1 Million - $20.6 Million
397,056 Added 126.03%
712,109 $32.1 Million
Q4 2023

Feb 14, 2024

BUY
$20.06 - $28.66 $5.15 Million - $7.36 Million
256,863 Added 441.42%
315,053 $8.66 Million
Q3 2023

Nov 14, 2023

SELL
$20.13 - $27.29 $1.09 Million - $1.48 Million
-54,355 Reduced 48.3%
58,190 $1.37 Million
Q2 2023

Aug 14, 2023

BUY
$18.33 - $27.18 $1.08 Million - $1.61 Million
59,176 Added 110.88%
112,545 $2.96 Million
Q1 2023

May 15, 2023

SELL
$14.25 - $20.5 $91,570 - $131,733
-6,426 Reduced 10.75%
53,369 $981,000
Q4 2022

Feb 14, 2023

BUY
$12.8 - $23.66 $765,376 - $1.41 Million
59,795 New
59,795 $925,000
Q2 2022

Aug 15, 2022

SELL
$13.98 - $29.25 $82,468 - $172,545
-5,899 Reduced 22.43%
20,401 $462,000
Q1 2022

May 16, 2022

SELL
$23.58 - $30.91 $1.99 Million - $2.61 Million
-84,583 Reduced 76.28%
26,300 $695,000
Q4 2021

Feb 14, 2022

SELL
$20.0 - $32.29 $2.6 Million - $4.19 Million
-129,869 Reduced 53.94%
110,883 $3.53 Million
Q3 2021

Nov 15, 2021

SELL
$16.48 - $27.23 $956,977 - $1.58 Million
-58,069 Reduced 19.43%
240,752 $5.3 Million
Q2 2021

Aug 16, 2021

BUY
$20.0 - $25.48 $1.54 Million - $1.96 Million
77,017 Added 34.72%
298,821 $6.3 Million
Q1 2021

May 17, 2021

BUY
$16.14 - $29.11 $637,142 - $1.15 Million
39,476 Added 21.65%
221,804 $4.63 Million
Q4 2020

Feb 16, 2021

BUY
$11.4 - $18.36 $699,002 - $1.13 Million
61,316 Added 50.67%
182,328 $3.2 Million
Q3 2020

Nov 16, 2020

BUY
$10.57 - $16.0 $312,332 - $472,784
29,549 Added 32.31%
121,012 $1.45 Million
Q2 2020

Aug 14, 2020

BUY
$10.5 - $17.36 $660,229 - $1.09 Million
62,879 Added 219.98%
91,463 $1.47 Million
Q1 2020

May 15, 2020

SELL
$11.34 - $19.44 $331,003 - $567,434
-29,189 Reduced 50.52%
28,584 $346,000
Q4 2019

Feb 14, 2020

BUY
$14.08 - $18.5 $813,443 - $1.07 Million
57,773 New
57,773 $813,000
Q4 2018

Feb 14, 2019

SELL
$11.46 - $20.81 $227,927 - $413,890
-19,889 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$18.47 - $26.39 $578,314 - $826,297
-31,311 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$16.77 - $22.76 $525,085 - $712,638
31,311 New
31,311 $713,000

Others Institutions Holding MRUS

About Merus N.V.


  • Ticker MRUS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,878,200
  • Market Cap $1.92B
  • Description
  • Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...
More about MRUS
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.